Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Neoplasms × Phlebotomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Polycythemia Vera 4 Myeloproliferative Disorders 3 Thymic aplasia 1 Thrombosis 1 Smoking 1 Sarcoma 1 Primary Dysautonomias 1 Polycythemia 1 Polycystic Ovary Syndrome 1 Metabolic Syndrome 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Insulin Resistance 1 Immunologic Deficiency Syndromes 1 Hyperandrogenism 1 Histiocytoma, Malignant Fibrous 1 Carcinoma, Squamous Cell 1

Interventions

Sorafenib 54 Bevacizumab 34 Oxaliplatin 21 Doxorubicin 19 Nivolumab 17 Fluorouracil 17 Radiosurgery 16 Gemcitabine 16 pembrolizumab 15 lenvatinib 14 durvalumab 14 Radiofrequency Ablation 14 Cisplatin 14 Capecitabine 14 atezolizumab 11 Leucovorin 11 Cyclophosphamide 10 Radiotherapy 9 Irinotecan 9 tremelimumab 8 Drug Therapy 8 Carboplatin 8 fludarabine 7 Ipilimumab 7 Everolimus 7 Cryosurgery 7 Chemotherapy, Adjuvant 7 Melphalan 6 toripalimab 5 camrelizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡